An engineered T-cell engager with selectivity for high mesothelin-expressing cells and activity in the presence of soluble mesothelin.
Snell D, Gunde T, Warmuth S, Chatterjee B, Brock M, Hess C, Johansson M, Simonin A, Spiga FM, Weinert C, Kirk N, Bassler N, Campos Carrascosa L, Flückiger N, Heiz R, Wagen S, Giezendanner N, Alberti A, Yaman Y, Mahler D, Diem D, Lichtlen P, Urech D.
Snell D, et al. Among authors: giezendanner n.
Oncoimmunology. 2023 Jul 12;12(1):2233401. doi: 10.1080/2162402X.2023.2233401. eCollection 2023.
Oncoimmunology. 2023.
PMID: 37456982
Free PMC article.